Dr. Sandy Kuo, MD

Dr. Kuo practices at Southern California Dermatology in Long Beach, California.

Dr. Kuo's NPI, 1023438785, was assigned on April 21, 2014. Dr. Kuo graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2014. Dr. Kuo holds California license 138192.

Dr. Kuo's primary practice is Southern California Dermatology, at 3828 Schaufele Ave, Long Beach, CA 90808 in Los Angeles County. The practice phone is (949) 644-0101.

Dr. Kuo's primary practice is Southern California Dermatology in Long Beach, California. The medical group on file is West Dermatology. Dmand AI also links Dr. Kuo to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kuo practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Kuo's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kuo is board certified in dermatology by the American Board of Dermatology. Dr. Kuo is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Kuo treats.

CMS data shows 3,651 Medicare services from Dr. Kuo across 13 procedure codes in 2024, for 713 Medicare patients. Medicare paid $158,591 for them. Every service was in an office.

CMS counts 713 Medicare patients who saw Dr. Kuo in 2024. The largest group is 65 to 74, with 381 patients. 75% of them have high cholesterol, and 61% have high blood pressure. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kuo's median patient age at 65, with 71% women.

In 2024, Dr. Kuo wrote 573 Medicare Part D claims for 234 patients. 94% of them were for generic drugs. CMS names the drug for 453 of them, across 18 drugs with 11 or more claims each, at $58,193 in total drug cost. In 2023, CMS named 542 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kuo for performance year 2024, reported as part of a group. Dr. Kuo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 481 procedures of removal of skin lesions by Dr. Kuo, more than 86% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Kuo, published from 2014 to 2015. 2014 was the busiest year, with 2. The most frequent topics are Rosacea, Patient Education as Topic and Physician-Patient Relations. Dr. Kuo has published most often in Cutis. Dr. Kuo's most frequent co-authors are Steven Richard Feldman, MD, Karen E. Huang, MD and Raja Kameswaran Sivamani, MD, MS.

CMS Open Payments shows 537 general payments to Dr. Kuo from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $2,039.

Dr. Kuo graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2014.

Dr. Kuo is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.